These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21119297)

  • 1. [New strategy in the treatment of vernal keratoconjunctivitis by calcineurin inhibitor eye drops].
    Ebihara N
    Arerugi; 2010 Nov; 59(11):1525-31. PubMed ID: 21119297
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
    Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
    Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis.
    Wan XC; Dimov V
    Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):543-9. PubMed ID: 24490943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D serum levels in children with vernal keratoconjunctivitis and disease control.
    Ghiglioni DG; Bruschi G; Gandini S; Osnaghi S; Peroni D; Marchisio P
    Int J Immunopathol Pharmacol; 2019; 33():2058738419833468. PubMed ID: 30843446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Safety and Efficacy of Tacrolimus 0.1% in Severe Pediatric Vernal Keratoconjunctivitis.
    Caputo R; Marziali E; de Libero C; Di Grande L; Danti G; Virgili G; Villani E; Mori F; Bacci GM; Lucenteforte E; Pucci N
    Cornea; 2021 Nov; 40(11):1395-1401. PubMed ID: 34029239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
    Vichyanond P; Kosrirukvongs P
    Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of eye allergies].
    Kari O; Saari KM
    Duodecim; 2012; 128(3):291-7. PubMed ID: 22428383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antiallergic eye drops "polynadyme": development, experimental and clinical studies].
    Maĭchuk IuF; Pozdniakov VI; Pozdniakova VV; Iakushina LN
    Vestn Oftalmol; 2006; 122(5):35-8. PubMed ID: 17087034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.
    Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R
    Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis.
    Esposito S; Fior G; Mori A; Osnaghi S; Ghiglioni D
    Paediatr Drugs; 2016 Oct; 18(5):347-55. PubMed ID: 27461427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment.
    Vichyanond P; Tantimongkolsuk C; Dumrongkigchaiporn P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P
    J Allergy Clin Immunol; 2004 Feb; 113(2):355-8. PubMed ID: 14767456
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus versus Cyclosporine- Comparative Evaluation as First line drug in Vernal keratoconjuctivitis.
    Kumari R; Saha BC; Sinha BP; Mohan N
    Nepal J Ophthalmol; 2017 Jul; 9(18):128-135. PubMed ID: 29634701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus 0.03% monotherapy for vernal keratoconjunctivitis--case series.
    Tam PM; Young AL; Cheng LL; Lam PT
    Br J Ophthalmol; 2010 Oct; 94(10):1405-6. PubMed ID: 20558422
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolated large limbal nodule as the presenting feature of vernal keratoconjunctivitis.
    Sugandhi P; Arora R
    J Pediatr Ophthalmol Strabismus; 2007; 44(1):49-50. PubMed ID: 17274337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of cyclosporine 0.05% in various ocular surface disorders].
    Maĭchuk DIu; Vasil'eva OA; Shokirova MM
    Vestn Oftalmol; 2014; 130(2):68-71. PubMed ID: 24864503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.